BridgeBio Pharma, Inc. — Investor Relations & Filings
BridgeBio Pharma, Inc. is a biotechnology company that discovers, creates, tests, and delivers transformative medicines for patients with genetic diseases and cancers with clear genetic drivers. The company's mission is to bridge the gap between advancements in genetic science and patients with unmet medical needs. It focuses on translating early scientific discoveries into patient solutions as quickly and safely as possible through a novel corporate model that combines a focus on drug products with an efficient development engine.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - BridgeBio Pharma, Inc. (0001743881) (Filer) | 2026-05-13 | English | |
| 8-K - BridgeBio Pharma, Inc. (0001743881) (Filer) | 2026-05-08 | English | |
| 10-Q - BridgeBio Pharma, Inc. (0001743881) (Filer) | 2026-05-07 | English | |
| 8-K - BridgeBio Pharma, Inc. (0001743881) (Filer) | 2026-05-07 | English | |
| ARS - BridgeBio Pharma, Inc. (0001743881) (Filer) | 2026-04-24 | English | |
| DEF 14A - BridgeBio Pharma, Inc. (0001743881) (Filer) | 2026-04-24 | English |
Browse filings by year
9 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Apontis Pharma AG
Develops and markets fixed-dose combination drugs (Single P…
|
APPH | DE | Manufacturing |
|
Appili Therapeutics Inc.
Biopharmaceutical company developing novel medicines for in…
|
APLI | CA | Manufacturing |
|
Applied BioCode
Develops and manufactures high-throughput multiplex molecul…
|
6598 | TW | Manufacturing |
|
Applied Therapeutics, Inc.
Clinical-stage biopharma developing novel drugs for rare me…
|
APLT | US | Manufacturing |
|
Aprogen Biologics Inc.
Develops and manufactures novel biologics and biosimilar an…
|
003060 | KR | Manufacturing |
|
Aprogen, Inc
Develops and manufactures biologic medicines, including bio…
|
007460 | KR | Manufacturing |
|
Aptabio Therapeutics Inc.
Develops drugs for intractable diseases by regulating oxida…
|
293780 | KR | Manufacturing |
|
Aptamer Sciences Inc
Clinical-stage company developing aptamer-based therapeutic…
|
291650 | KR | Manufacturing |
|
Aptorum Group Ltd
Clinical-stage biopharma developing therapeutics for oncolo…
|
APM | US | Manufacturing |
|
Aptus Pharma Limited
Develops and manufactures cardiovascular, metabolic, and ga…
|
544529 | IN | Manufacturing |
BridgeBio Pharma, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30604/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30604 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30604 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30604 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30604}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BridgeBio Pharma, Inc. (id: 30604)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.